首页> 外文期刊>Ophthalmic Research: Journal for Research in Experimental and Clinical Ophthalmology >Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
【24h】

Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.

机译:醋酸曲安奈德联合玻璃体切除术联合或不联合玻璃体切除术联合治疗黄斑水肿伴视网膜分支静脉阻塞的疗效比较研究。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: To compare the efficacy ofa combination therapy of triamcinolone acetonide (TA) administration with and without vitrectomy in eyes with macular edema associated with branch retinal vein occlusion over a 1-year period. METHODS: A retrospective, case-control study was conducted in 15 eyes of 15 patients with macular edema associated with branch retinal vein occlusion. Eight eyes underwent simultaneous intravitreal and posterior sub-Tenon capsule injections of TA (TA-injected group). Seven eyes underwent vitrectomy with intravitreal or simultaneous posterior sub-Tenon capsule injection of TA (vitrectomy with TA group). Macular thickness and visual acuity were measured before and at 1, 3, 6 and 12 months after the therapy. RESULTS: Twelve months after the therapy, mean visual acuity improved significantly from baseline in both the TA-injected (p = 0.0069) and vitrectomy with TA groups (p = 0.0145). Macular thickness also improved significantly in both the TA-injected (p = 0.0065) and vitrectomy with TA groups (p = 0.0058). At 12 months after the therapy, there was no significant difference in visual acuity and macular thickness between the two groups (p = 0.3308 and 0.3711, respectively). At the early postoperative stage (1 and 3 months after the therapy), the central macular thickness in the TA-injected group was significantly less than that in the vitrectomy with TA group (p = 0.0140 and 0.0275, respectively); there was no significant difference in visual acuity between the two groups (p = 0.0796 and 0.3753, respectively). CONCLUSION: TA injection without vitrectomy was as effective as a combination therapy of TA injection with vitrectomy.
机译:目的:比较在1年的时间内合并或不合并玻璃体切除术的曲安奈德(TA)联合治疗对伴有视网膜分支静脉阻塞的黄斑水肿眼的治疗效果。方法:对15例黄斑水肿伴视网膜分支静脉阻塞的15只眼的15只眼进行了回顾性病例对照研究。八只眼同时接受玻璃体腔内注射和后部Tenon囊内TA注射(TA注射组)。七只眼接受玻璃体切除术,玻璃体腔内注射或同时行Tenon囊后注射(TA组玻璃体切除术)。在治疗之前和之后1、3、6和12个月测量黄斑厚度和视敏度。结果:治疗十二个月后,TA组(p = 0.0069)和玻璃体切除术(TA组)的平均视力均较基线明显改善(p = 0.0145)。在注射TA的组(p = 0.0065)和玻璃体切除术(使用TA组)中,黄斑厚度也显着改善(p = 0.0058)。治疗后12个月,两组的视敏度和黄斑厚度无明显差异(分别为p = 0.3308和0.3711)。在术后早期(治疗后的1和3个月),TA注射组的中央黄斑厚度明显小于TA组的玻璃体切除术(分别为p = 0.0140和0.0275)。两组的视敏度无显着差异(分别为p = 0.0796和0.3753)。结论:无玻璃体切除术的TA注射与玻璃体切除术的TA注射联合治疗一样有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号